DXCM vs EVGOW · P/E 63, rev $2.50B vs rev $256.8M
DexCom Inc (DXCM) versus EVgo Equity Warrants (EVGOW) — a side-by-side from cached financials, not a winner call.
DexCom Inc (DXCM) is a medical devices company listed on US.
EVgo Equity Warrants (EVGOW) is a specialty retail company listed on US.
Latest reported DXCM revenue for 2026-06-30 was $2.50B. Net income was $448.6M. DXCM currently screens at market cap $32.84B and trailing P/E 62.5.
Latest reported EVGOW revenue for 2024-12-31 was $256.8M. Net income was -$126.7M. Revenue was up 59.6% from 2023-12-31 to 2024-12-31. EVGOW currently screens at market cap $0.
DXCM currently screens at market cap $32.84B and trailing P/E 62.5. EVGOW currently screens at market cap $0.
Not investment advice. Open the DXCM and EVGOW stock pages for the full models.
Not investment advice.